July 20, 2021 (Newswire.com) –
Experimental Biology and Medication (EBM), a multidisciplinary biomedical analysis journal, is working to advance our understanding of COVID-19. The Editor-in-Chief is presently dealing with manuscripts which concentrate on COVID to make sure that every paper undergoes a fast but rigorous evaluate. EBM’s writer, SAGE, is dedicated to helping in spreading analysis on COVID by guaranteeing all accepted manuscripts protecting the virus are processed and revealed on-line as shortly as doable and can be found through open entry.
Experimental Biology and Medication not too long ago revealed 4 articles targeted on COVID-19. Gasparini et al. (in press) study ocular transmission of COVID-19 in Brazilian sufferers. Drs. Jogaleker, Veerbathini and Gangdaran (in press) evaluate the affect of COVID variants on the continued pandemic and vaccine efficacy. Drs. Jogaleker, Veerabathini and Patel (2021) evaluate current research on repurposed medication that could be efficient in treating COVID-19. Lastly, Banerjee et al. (in press) report a brand new software to stop COVID virus replication.
Dr. Gasparini, College of Medical Sciences on the College of Campinas (Brazil) and corresponding writer for “Identification of SARS-CoV-2 on the ocular floor in a cohort of COVID-19 sufferers from Brazil,” said, “Though SARS-CoV-2 was discovered on the ocular floor of a minority of COVID-19 sufferers, our analysis reveals that ocular transmission of SARS-CoV-2 is a chance that must be thought of, particularly within the hospital surroundings. There’s a potential threat for well being and eyecare professionals to be contaminated throughout shut contact with sufferers.”
In the meantime, the unfold of variants all through the world has made mitigating the COVID-19 pandemic tough. Dr. Manasi P. Jogaleker, Brigham and Girls’s Hospital (USA) and corresponding writer for “SARS-CoV-2 Variants: A Double-Edged Sword?,” stated “SARS-CoV-2 evolution has introduced challenges in mitigating the COVID-19 disaster throughout the globe. Variants of a number of lineages have emerged in a number of nations and are spreading worldwide as we start to raise journey bans and loosen restrictions on masks carrying and distancing. This text sheds gentle on the mutations underlying every variant, their affect on viral transmissibility, and the efficacy of antibodies generated by vaccines or pure an infection, and people current in convalescent plasma.”
The fast unfold and surge of COVID-19 instances all through the world require the fast improvement of doable remedies. Dr. Manasi P. Jogaleker, Brigham and Girls’s Hospital (USA) and corresponding writer for “COVID-19: Antiviral Brokers and Enzyme Inhibitors/Receptor Blockers in Improvement,” stated, “This text discusses the mechanism of motion, antagonistic occasions, and medical trials involving choose antiviral brokers, receptor blockers, and steroids. Whereas vaccines are being administered in a number of nations, many creating nations are nonetheless going through vaccine shortages, leading to delays in vaccinating their populations and a surge in COVID-19 infections. This paper will present very important data for clinicians to successfully deal with sufferers and deal with the surge in instances.”
Lastly, the unfold of COVID-19 additionally sparked a push for modern anti-viral remedies. Dr. Bithin Kumar Maji, Serampore School (India) and corresponding writer for Banerjee et al.’s “Manipulation of Genes May Inhibit SARS-CoV-2 An infection that Causes COVID-19 Pandemics,” stated that their evaluate “is especially targeted on the choice method of administration towards the pandemic to degrade the goal sequence of RNA in SARS-CoV-2 by viral inhibition. This gene manipulation know-how could cut back the an infection and mortality charge globally. This antiviral tool-based know-how could be delivered to contaminated sufferers through nebulizer, nasal spray or nasal drop.”
Whereas discussing the significance of those research, Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medication, stated, “The 4 COVID-19 associated articles mentioned above cowl vital topics together with ocular transmission of the virus, new variants, novel approaches to remedy, and ongoing medical trials. EBM continues to attempt to deliver the scientific and medical communities the required data to grasp the progress on present and future therapeutic approaches towards SARS-CoV-2.”
Experimental Biology and Medication, first established in 1903, is the journal of the Society of Experimental Biology and Medication and is devoted to the publication of multidisciplinary and inter-disciplinary analysis within the biomedical sciences. To study extra in regards to the Society and the way to develop into a member, go to www.sebm.org. For anybody eager about submitting a manuscript for consideration or viewing different articles revealed within the journal, please go to http://ebm.sagepub.com.
Supply: Experimental Biology and Medication